Welcome to Jubilant Life Sciences– An integrated global pharmaceutical and life sciences company.
Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacturing and supplying of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. We also provide services in Contract Manufacturing of Sterile Injectables & Ointments, Creams & Liquids and Drug Discovery & Development.
Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products and services across geographies, constantly investing in various growth platforms and promoting a culture of innovation. Jubilant Life Sciences has been ranked No. 6 amongst the Top 10 global contract manufacturing & services outsourcing players of the pharmaceutical industry (Source: UNCTAD, 2011).
We are engaged in continuous improvement of products and processes to enhance the quality of production and cost competitiveness in order to build value for our customers. Jubilant Life Sciences serves its customers globally with sales in over 100 countries and ground presence in India, North America, Europe and China. We are well recognised as a ‘Partner of Choice’ by leading life sciences companies worldwide. Jubilant has relationship with 19 of Top 20 pharmaceutical companies and 6 amongst top 10 agrochemical companies across the globe.
Over the years, Jubilant Life Sciences has extended its footprint beyond India in the USA, Canada, Europe, and other countries across the globe. We have also expanded the business by building capabilities internally, through strategic expansions and acquisitions This resulted in a network of 7 world class manufacturing facilities in India and 3 in North America and a team of over 6300 people across the globe with ~ 1400 in North America and ~1000 in R&D.
Our multi-location presence helps us in getting closer to customers and serving them better with the best in class products developed most efficiently, economically with speed to market.
Jubilant Life Sciences’ progress in diverse businesses has been made possible through the contribution of R&D; for quality, non-infringing process for product development and cost reduction through process innovation. Innovation at Jubilant is backed by strong chemistry, bio science expertise and the knowledge bank created over the years. We have harnessed our strengths – a strong R&D team, modern R&D facilities, command over cheap technologies and economies of scale into a synergistic organic entity, continuously creating and nurturing high quality products and technologies.
In line with Jubilant Life Sciences continued focus on sustainability of business, we aim at improving stakeholder value through improved eco efficient use of capital and natural resources. Jubilant’s approach to sustainable development focuses on the triple bottom line of Economics, Environment and Social performance. We are committed and working on various areas for energy conservation and climate change mitigation. Our sustainability efforts have been reported through a Corporate Sustainability Report since 2003 and this report has been receiving GRI G3.1 A+ level & GRI Check, since 2007 from Global Reporting Initiative (GRI). This reflects Jubilant Life Sciences commitment towards sustainable development and continued efforts directed towards protecting the environment wherever we operate.
Healthcare Solutions through Synergy
Corporate Social Responsibility is an integral part of how Jubilant Life Sciences conducts business and how the efforts are directed towards community development through focus on primary education, basic healthcare service, and livelihood generation programs focused on improving the employability of women and local youth.
We have been recognised with several awards and recognitions, which bear testimony to our commitment towards operational excellence, innovation, corporate governance and social responsibility.
Jubilant Life Sciences is committed to leverage innovation and scale of operations at every step of the pharmaceutical value chain to deliver value to our stakeholders.